The RUNX family: developmental regulators in cancer (Q38319972)

2 September 2017

1 reference

title

The RUNX family: developmental regulators in cancer (English)

1 reference

2 September 2017

Yoshiaki Ito

1

1 reference

2 September 2017

Suk-Chul Bae

series ordinal

2

1 reference

2 September 2017

Linda Shyue Huey Chuang

series ordinal

3

1 reference

2 September 2017

language of work or name

English

0 references

publication date

16 January 2015

1 reference

2 September 2017

Nature Reviews Cancer

1 reference

2 September 2017

15

1 reference

2 September 2017

2

1 reference

2 September 2017

81-95

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc3877

2 September 2017

0 references

cites work

RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes

1 reference

RUNX transcription factors as key targets of TGF-beta superfamily signaling

21 January 2018

1 reference

RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis

21 January 2018

1 reference

Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells

21 January 2018

1 reference

Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation

21 January 2018

1 reference

A Src family kinase-Shp2 axis controls RUNX1 activity in megakaryocyte and T-lymphocyte differentiation

21 January 2018

1 reference

Identification of RUNX3 as a component of the MST/Hpo signaling pathway

21 January 2018

1 reference

A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator

21 January 2018

1 reference

RUNX1 mutations in clonal myeloid disorders: from conventional cytogenetics to next generation sequencing, a story 40 years in the making

21 January 2018

1 reference

Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone.

21 January 2018

1 reference

Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogene

21 January 2018

1 reference

The common retroviral insertion locus Dsi1 maps 30 kilobases upstream of the P1 promoter of the murine Runx3/Cbfa3/Aml2 gene

21 January 2018

1 reference

Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks

21 January 2018

1 reference

Structure and regulated expression of mammalian RUNX genes

21 January 2018

1 reference

RUNX family: Regulation and diversification of roles through interacting proteins

21 January 2018

1 reference

Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains

21 January 2018

1 reference

Direct recruitment of polycomb repressive complex 1 to chromatin by core binding transcription factors.

21 January 2018

1 reference

Phosphorylation of RUNX1 by cyclin-dependent kinase reduces direct interaction with HDAC1 and HDAC3.

21 January 2018

1 reference

Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter

21 January 2018

1 reference

The ability of MLL to bind RUNX1 and methylate H3K4 at PU.1 regulatory regions is impaired by MDS/AML-associated RUNX1/AML1 mutations.

21 January 2018

1 reference

Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein

21 January 2018

1 reference

Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation

21 January 2018

1 reference

PEBP2-beta/CBF-beta-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis

21 January 2018

1 reference

The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability

21 January 2018

1 reference

The corepressor mSin3A regulates phosphorylation-induced activation, intranuclear location, and stability of AML1.

21 January 2018

1 reference

Phosphorylation, acetylation and ubiquitination: the molecular basis of RUNX regulation

21 January 2018

1 reference

Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation

21 January 2018

1 reference

Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity

21 January 2018

1 reference

Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferation

21 January 2018

1 reference

Expression of the AML-1 oncogene shortens the G(1) phase of the cell cycle

21 January 2018

1 reference

Cyclin D1-cdk4 induce runx2 ubiquitination and degradation

21 January 2018

1 reference

AML1/RUNX1 phosphorylation by cyclin-dependent kinases regulates the degradation of AML1/RUNX1 by the anaphase-promoting complex

21 January 2018

1 reference

Mitotic control of RUNX2 phosphorylation by both CDK1/cyclin B kinase and PP1/PP2A phosphatase in osteoblastic cells

21 January 2018

1 reference

Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2.

21 January 2018

1 reference

Mitotic retention of gene expression patterns by the cell fate-determining transcription factor Runx2.

21 January 2018

1 reference

Addiction of t(8;21) and inv(16) acute myeloid leukemia to native RUNX1.

21 January 2018

1 reference

BET domain co-regulators in obesity, inflammation and cancer

21 January 2018

1 reference

Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma

21 January 2018

1 reference

Multiple phosphorylation sites are important for RUNX1 activity in early hematopoiesis and T-cell differentiation.

21 January 2018

1 reference

The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation

21 January 2018

1 reference

Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia

21 January 2018

1 reference

Disease mutations in RUNX1 and RUNX2 create nonfunctional, dominant-negative, or hypomorphic alleles.

21 January 2018

1 reference

Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia

21 January 2018

1 reference

RUNX1 translocations and fusion genes in malignant hemopathies

21 January 2018

1 reference

t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1

21 January 2018

1 reference

A stable transcription factor complex nucleated by oligomeric AML1–ETO controls leukaemogenesis

21 January 2018

1 reference

Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia

21 January 2018

1 reference

Chromosome translocations and covert leukemic clones are generated during normal fetal development

21 January 2018

1 reference

Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells

21 January 2018

1 reference

Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia

21 January 2018

1 reference

RUNX1 DNA-binding mutants, associated with minimally differentiated acute myelogenous leukemia, disrupt myeloid differentiation.

21 January 2018

1 reference

Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL.

21 January 2018

1 reference

Sequence analysis of mutations and translocations across breast cancer subtypes

21 January 2018

1 reference

Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines

21 January 2018

1 reference

A molecular signature of metastasis in primary solid tumors

21 January 2018

1 reference

An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome

21 January 2018

1 reference

Increased dosage of the RUNX1/AML1 gene: a third mode of RUNX leukemia?

21 January 2018

1 reference

Defining a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer.

21 January 2018

1 reference

A differential gene expression profile reveals overexpression of RUNX1/AML1 in invasive endometrioid carcinoma.

21 January 2018

1 reference

Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma

21 January 2018

1 reference

The Role of RUNX2 in Osteosarcoma Oncogenesis

21 January 2018

1 reference

Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy

21 January 2018

1 reference

Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions

21 January 2018

1 reference

Deletion mapping on chromosome 1p in well-differentiated gastric cancer

21 January 2018

1 reference

Genomic instability in 1p and human malignancies

21 January 2018

1 reference

Frequent allelic imbalance suggests involvement of a tumor suppressor gene at 1p36 in the pathogenesis of human lung cancers

21 January 2018

1 reference

The quest for the 1p36 tumor suppressor

21 January 2018

1 reference

Genomic and functional evidence for an ARID1A tumor suppressor role

21 January 2018

1 reference

RUNX3 is multifunctional in carcinogenesis of multiple solid tumors

21 January 2018

1 reference

RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors.

21 January 2018

1 reference

DNA methylation-based biomarkers in bladder cancer

21 January 2018

1 reference

RUNX3 methylation reveals that bladder tumors are older in patients with a history of smoking.

21 January 2018

1 reference

Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer.

21 January 2018

1 reference

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

21 January 2018

1 reference

DNA methylation of Runx1 regulatory regions correlates with transition from primitive to definitive hematopoietic potential in vitro and in vivo

21 January 2018

1 reference

RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer

21 January 2018

1 reference

Causal relationship between the loss of RUNX3 expression and gastric cancer

21 January 2018

1 reference

RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.

21 January 2018

1 reference

RUNX3 functions as an oncogene in ovarian cancer

21 January 2018

1 reference

RUNX3 protein is overexpressed in human basal cell carcinomas

21 January 2018

1 reference

RUNX3 protein is overexpressed in human epithelial ovarian cancer

21 January 2018

1 reference

RUNX3 has an oncogenic role in head and neck cancer

21 January 2018

1 reference

AML1/RUNX1 increases during G1 to S cell cycle progression independent of cytokine-dependent phosphorylation and induces cyclin D3 gene expression

21 January 2018

1 reference

The bone-specific expression of Runx2 oscillates during the cell cycle to support a G1-related antiproliferative function in osteoblasts

21 January 2018

1 reference

Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis

21 January 2018

1 reference

AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis

21 January 2018

1 reference

Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia.

21 January 2018

1 reference

Targeting transcription regulation in cancer with a covalent CDK7 inhibitor

21 January 2018

1 reference

Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures

21 January 2018

1 reference

Regulation of bone development and extracellular matrix protein genes by RUNX2.

21 January 2018

1 reference

Rb regulates fate choice and lineage commitment in vivo

21 January 2018

1 reference

The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation

21 January 2018

1 reference

Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma

21 January 2018

1 reference

Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling

21 January 2018

1 reference

Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancer

21 January 2018

1 reference

RUNX proteins in transcription factor networks that regulate T-cell lineage choice

21 January 2018

1 reference

Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development.

21 January 2018

1 reference

Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development.

21 January 2018

1 reference

TCF-1 and LEF-1 act upstream of Th-POK to promote the CD4(+) T cell fate and interact with Runx3 to silence Cd4 in CD8(+) T cells

21 January 2018

1 reference

Loss of Runx3 is a key event in inducing precancerous state of the stomach

21 January 2018

1 reference

The RUNX3 gene--sequence, structure and regulated expression

21 January 2018

1 reference

AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization

21 January 2018

1 reference

Genomic promoter occupancy of runt-related transcription factor RUNX2 in Osteosarcoma cells identifies genes involved in cell adhesion and motility

21 January 2018

1 reference

The RUNX family in breast cancer: relationships with estrogen signaling

21 January 2018

1 reference

TGFbeta signalling: a complex web in cancer progression

21 January 2018

1 reference

Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter

21 January 2018

1 reference

RUNX3 cooperates with FoxO3a to induce apoptosis in gastric cancer cells

21 January 2018

1 reference

The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis

21 January 2018

1 reference

Runx1 is a co-activator with FOXO3 to mediate transforming growth factor beta (TGFbeta)-induced Bim transcription in hepatic cells

21 January 2018

1 reference

Runx1 modulates developmental, but not injury-driven, hair follicle stem cell activation.

21 January 2018

1 reference

Runx1 modulates adult hair follicle stem cell emergence and maintenance from distinct embryonic skin compartments

21 January 2018

1 reference

Canonical WNT Signaling Promotes Osteogenesis by Directly StimulatingRunx2Gene Expression

21 January 2018

1 reference

RUNX3 in oncogenic and anti-oncogenic signaling in gastrointestinal cancers.

21 January 2018

1 reference

Runx1 is a tumor suppressor gene in the mouse gastrointestinal tract.

21 January 2018

1 reference

Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung.

21 January 2018

1 reference

Genome-wide analysis of estrogen receptor alpha DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated transcriptional activation

21 January 2018

1 reference

Modulation of Runx2 activity by estrogen receptor-alpha: implications for osteoporosis and breast cancer

21 January 2018

1 reference

Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2.

21 January 2018

1 reference

RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor α

21 January 2018

1 reference

Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome

21 January 2018

1 reference

p53--a Jack of all trades but master of none

21 January 2018

1 reference

Selective activation of p53-mediated tumour suppression in high-grade tumours

21 January 2018

1 reference

Stage-specific sensitivity to p53 restoration during lung cancer progression.

21 January 2018

1 reference

The RUNX genes: gain or loss of function in cancer

21 January 2018

1 reference

Oncogene-induced senescence: an essential role for Runx

21 January 2018

1 reference

Runx2 disruption promotes immortalization and confers resistance to oncogene-induced senescence in primary murine fibroblasts

21 January 2018

1 reference

The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.

21 January 2018

1 reference

Runx2 deficiency and defective subnuclear targeting bypass senescence to promote immortalization and tumorigenic potential.

21 January 2018

1 reference

RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress

21 January 2018

1 reference

Functional interplay between p63 and p53 controls RUNX1 function in the transition from proliferation to differentiation in human keratinocytes.

21 January 2018

1 reference

MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma

21 January 2018

1 reference

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

21 January 2018

1 reference

RUNX1 transformation of primary embryonic fibroblasts is revealed in the absence of p53.

21 January 2018

1 reference

C-terminal mutation of RUNX1 attenuates the DNA-damage repair response in hematopoietic stem cells.

21 January 2018

1 reference

21 January 2018

1 reference

RUNX3 modulates DNA damage-mediated phosphorylation of tumor suppressor p53 at Ser-15 and acts as a co-activator for p53.

21 January 2018

1 reference

21 January 2018

1 reference

Runx3 interacts with DNA repair protein Ku70.

21 January 2018

1 reference

Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage

21 January 2018

1 reference

A regulatory circuit controlling Itch-mediated p73 degradation by Runx.

21 January 2018

1 reference

Disruption of Runx1 and Runx3 leads to bone marrow failure and leukemia predisposition due to transcriptional and DNA repair defects.

21 January 2018

1 reference

T helper 17 cells play a critical pathogenic role in lung cancer

21 January 2018

1 reference

Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms

21 January 2018

1 reference

Mutual expression of the transcription factors Runx3 and ThPOK regulates intestinal CD4⁺ T cell immunity

21 January 2018

1 reference

Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia

21 January 2018

1 reference

Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells

21 January 2018

1 reference

A role for RUNX3 in inflammation-induced expression of IL23A in gastric epithelial cells.

21 January 2018

1 reference

Runx3 protects gastric epithelial cells against epithelial-mesenchymal transition-induced cellular plasticity and tumorigenicity

21 January 2018

1 reference

Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells.

21 January 2018

1 reference

21 January 2018

1 reference

The transcription factor Runx3 represses the neurotrophin receptor TrkB during lineage commitment of dorsal root ganglion neurons

21 January 2018

1 reference

Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB

21 January 2018

1 reference

RUNX1 and RUNX2 upregulate Galectin-3 expression in human pituitary tumors

21 January 2018

1 reference

Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells

21 January 2018

1 reference

Physical and functional interaction of Runt-related protein 1 with hypoxia-inducible factor-1alpha

21 January 2018

1 reference

RUNX3 inhibits hypoxia-inducible factor-1α protein stability by interacting with prolyl hydroxylases in gastric cancer cells

21 January 2018

1 reference

Runx2 protein stabilizes hypoxia-inducible factor-1α through competition with von Hippel-Lindau protein (pVHL) and stimulates angiogenesis in growth plate hypertrophic chondrocytes

21 January 2018

1 reference

Distinct in vivo requirements for establishment versus maintenance of transcriptional repression.

21 January 2018

1 reference

Unexpected repertoire of metazoan transcription factors in the unicellular holozoan Capsaspora owczarzaki

21 January 2018

1 reference

Is Runx a linchpin for developmental signaling in metazoans?

21 January 2018

1 reference

The C. elegans RUNX transcription factor RNT-1/MAB-2 is required for asymmetrical cell division of the T blast cell.

21 January 2018

1 reference

mab-2 encodes RNT-1, a C. elegans Runx homologue essential for controlling cell proliferation in a stem cell-like developmental lineage

21 January 2018

1 reference

RNT-1, the C. elegans homologue of mammalian RUNX transcription factors, regulates body size and male tail development

21 January 2018

1 reference

Stabilization of RNT-1 protein, runt-related transcription factor (RUNX) protein homolog of Caenorhabditis elegans, by oxidative stress through mitogen-activated protein kinase pathway

21 January 2018

1 reference

Runx expression is mitogenic and mutually linked to Wnt activity in blastula-stage sea urchin embryos

21 January 2018

1 reference

Runt and Lozenge function in Drosophila development

21 January 2018

1 reference

Lozenge directly activates argos and klumpfuss to regulate programmed cell death

21 January 2018

1 reference

Notch cooperates with Lozenge/Runx to lock haemocytes into a differentiation programme

21 January 2018

1 reference

Elephant shark genome provides unique insights into gnathostome evolution

21 January 2018

1 reference

The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo

21 January 2018

1 reference

Cbfβ deletion in mice recapitulates cleidocranial dysplasia and reveals multiple functions of Cbfβ required for skeletal development.

21 January 2018

1 reference

Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia

21 January 2018

1 reference

Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11.

21 January 2018

1 reference

Structural basis for hijacking CBF-β and CUL5 E3 ligase complex by HIV-1 Vif.

21 January 2018

1 reference

CBFβ stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression.

21 January 2018

1 reference

High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia

21 January 2018

1 reference

RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation.

21 January 2018

1 reference

Nicotinamide inhibits growth of carcinogen induced mouse bladder tumor and human bladder tumor xenograft through up-regulation of RUNX3 and p300

21 January 2018

1 reference

Whole-genome analysis informs breast cancer response to aromatase inhibition

31 March 2020

1 reference

Allelic imbalance at 1p36 may predict prognosis of chemoradiation therapy for bladder preservation in patients with invasive bladder cancer

31 March 2020

1 reference

RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization.

31 March 2020

1 reference

Prognostic implication of immunohistochemical Runx2 expression in osteosarcoma.

31 March 2020

1 reference

A genome-wide regulatory network identifies key transcription factors for memory CD8⁺ T-cell development.

31 March 2020

1 reference

Enforced expression of Runx2 perturbs T cell development at a stage coincident with beta-selection

31 March 2020

1 reference

Runx1 protects hematopoietic stem/progenitor cells from oncogenic insult

31 March 2020

1 reference

A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with myc

31 March 2020

1 reference

Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo

31 March 2020

1 reference

The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia

31 March 2020

1 reference

Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene

31 March 2020

1 reference

12 December 2020

Cell growth regulatory role of Runx2 during proliferative expansion of preosteoblasts

1 reference

12 December 2020

Overexpression of the AML1 proto-oncoprotein in NIH3T3 cells leads to neoplastic transformation depending on the DNA-binding and transactivational potencies.

1 reference

12 December 2020

Proviral insertion indicates a dominant oncogenic role for Runx1/AML-1 in T-cell lymphoma.

1 reference

12 December 2020

Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRC3877

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference